|
|
Personal data sheet |
Print preview VALIDITY EXPIRED personal data approved: 2013. II. 02. Publications |
2012
manual entry, 2013. I. 31. |
Tie Y, Wang YF, Boross PI, Chiu TY, Ghosh AK, Tozser J, Louis JM, Harrison RW, Weber IT.: Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors., Protein Science, pp. 339-350 type of document: Journal paper/Article impact factor: 2.798 language: English
|
2012
manual entry, 2014. I. 02. |
Csősz E, Boross P, Csutak A, Berta A, Toth F, Póliska S, Török Z, Tozser J: Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy., Journal of proteomics, pp. 2196-2204 type of document: Journal paper/Article impact factor: 4.878 language: English
|
2008
manual entry, 2010. IX. 30. |
Kádas J, Boross P, Weber IT, Bagossi P, Matúz K, Tözsér J.: C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity., The Biochemical Journal, pp. 357-364 type of document: Journal paper/Article impact factor: 5.155 number of independent citations: 1 language: English
|
2008
manual entry, 2010. IX. 30. |
Eizert H, Bander P, Bagossi P, Sperka T, Miklóssy G, Boross P, Weber IT, Tözsér J.: Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site., Journal of Virology, pp. 10111-10117 type of document: Journal paper/Article impact factor: 5.150 number of independent citations: 3 language: English
|
2007
manual entry, 2010. IX. 23. |
Wang YF, Tie Y, Boross PI, Tozser J, Ghosh AK, Harrison RW, Weber IT.: Potent New Antiviral Compound Shows Similar Inhibition and Structural Interactions with Drug Resistant Mutants and Wild Type HIV-1 Protease., J Med Chem., pp. 4509-4515 type of document: Journal paper/Article impact factor: 5.120 number of independent citations: 5 language: English
|
2006
manual entry, 2010. IX. 23. |
Liu, F., Kovalevsky, A.Y., Louis, J.M., Boross, P.I., Wang, YF., Harrison, R.W., Weber, I.T.: Mechanism of drug resistance revealed by the crystal structure of the unliganded HIV-1 protease with F53L mutation, Journal of Molecular Biology 358(5):1191-9., pp. 1191-1199 type of document: Journal paper/Article impact factor: 4.890 number of independent citations: 15 language: English
|
2005
manual entry, 2010. IX. 23. |
Liu F, Boross PI, Wang YF, Tozser J, Louis JM, Harrison RW, Weber IT.: Kinetic, stability, and structural changes in high-resolution crystal structures of HIV-1 protease with drug-resistant mutations L24I, I50V, and G73S., J Mol Biol. 354(4):789-800., pp. 789-800 type of document: Journal paper/Article impact factor: 5.230 number of independent citations: 10 language: English
|
2004
manual entry, 2010. IX. 23. |
Kadas, J., Weber, I.T., Bagossi, P., Miklossy, G., Boross, P., Oroszlan, S., Tozser, J.: Narrow substrate specificity and sensitivity towards ligand binding site mutations of human T-cell leukemia virus type-1 protease., Journal of Biological Chemistry 279(26), 27148-57, pp. 27148-27157 type of document: Journal paper/Article impact factor: 6.360 number of independent citations: 10 language: English
|
2004
manual entry, 2010. IX. 23. |
*Tie, Y./ *Boross, P., Wang, Y.F., Gaddis, L., Hussain, A.K., Leshchenko, S., Ghosh, A.K., Louis, J.M., Harrison, R.W., Weber, I.T.: High Resolution Crystal Structures of HIV-1 Protease with a Potent Non-peptide Inhibitor (UIC-94017) Active Against Multi-drug-resistant Clinical Strains., Journal of Molecular Biology 23;338(2):341-52., pp. 341-352 type of document: Journal paper/Article impact factor: 5.540 number of independent citations: 29 language: English
|
1999
manual entry, 2010. IX. 30. |
Boross, P., Bagossi P., Copeland, T.D., Oroszlan, S., Louis, J.M., Tozser, J.: Effect of substrate residues on the P2 ' preference of retroviral proteinases., European Journal of Biochemistry, 264, 921-929., pp. 921-929 type of document: Journal paper/Article impact factor: 3.310 number of independent citations: 7 language: English
|
| Number of independent citations to these publications: | 80 |
|
|
|
|
|